Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-14

Clinical Trial Update: Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01 [NA]

View source ↗

Summary

Completed EEG study update on AKL-T01 for attention in ADHD; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AKL-T01

Snippet

Sponsor: Akili Interactive Labs, Inc. | Conditions: Attention Deficit Hyperactivity Disorder | NA | Status: COMPLETED | Results posted: 2023-11-14